Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

腎臓科. 腎臓科. 死亡率を低減し,意識を高める.

A Schieppati1, G Remuzzi

  • 1Mario Negri Institute for Pharmacological Research, Ospedale Riuniti, Bergamo, Italy.

Lancet (London, England)
|January 1, 1999
PubMed
まとめ

No abstract available in PubMed .

関連する実験動画

関連する概念動画

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe.

The European journal of health economics : HEPAC : health economics in prevention and care·2016
Same author

Takayasu's arteritis: A study of 104 Italian patients.

Arthritis and rheumatism·2005
Same author

Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.

The Cochrane database of systematic reviews·2004
Same author

Proteinuria and its consequences in renal disease.

Acta paediatrica (Oslo, Norway : 1992). Supplement·2004
Same author

Modulating the profit motive to meet needs of the less-developed world.

Lancet (London, England)·2001
Same author

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data.

Annals of internal medicine·2001
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
関連記事をすべて見る